| 000 | 01009 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517114847.0 | ||
| 264 | 0 | _c20171113 | |
| 008 | 201711s 0 0 eng d | ||
| 022 | _a1097-4547 | ||
| 024 | 7 |
_a10.1002/jnr.23791 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSands, Scott A | |
| 245 | 0 | 0 |
_aSubstrate reduction therapy for Krabbe's disease. _h[electronic resource] |
| 260 |
_bJournal of neuroscience research _c11 2016 |
||
| 300 |
_a1261-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aGalactosylceramidase _xdeficiency |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukodystrophy, Globoid Cell _xenzymology |
| 700 | 1 | _aLeVine, Steven M | |
| 773 | 0 |
_tJournal of neuroscience research _gvol. 94 _gno. 11 _gp. 1261-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jnr.23791 _zAvailable from publisher's website |
| 999 |
_c26427632 _d26427632 |
||